Human in Motion Robotics

Human in Motion Robotics operates at the intersection of medical devices, robotics, and rehabilitation, with XoMotion as its core wearable lower-limb exoskeleton. Its stated focus is hands-free, self-balancing mobility for users with lower-extremity motor deficits, including support for walking tasks such as stairs, turns, and slopes. XoMotion-R extends the platform toward ambulatory training in rehabilitation centers, while the Research Collaboration and Open Control Platform is intended to let academic, clinical, and robotics researchers test control approaches. The company reports sensor systems, multimodal controllers, and patented robotic joint mechanisms spanning the hip, knee, and ankle; its portfolio also includes 10 granted patents. Those features differentiate its proposition around balance and complex movement rather than assistance limited to straightforward walking. The company’s first clinical delivery to Synaptic Health in June 2025 and reported Canadian availability in 2026 provide evidence of movement beyond development.

Founded in 2016, Human in Motion Robotics has moved from early non-equity support and seed financing toward larger institutional funding and clinical commercialization. Its disclosed funding totals US$12.72 million across six rounds, including a US$7.35 million Series A led by Beno Holdings on May 29, 2023, and a US$2.19 million-equivalent grant led by Pacific Economic Development Canada on May 11, 2026. Earlier recorded financing includes seed rounds in 2018 and 2020, a 2020 grant, and non-equity assistance in 2017 for which no amount is disclosed. Product milestones mark a second inflection point: XoMotion received Canadian regulatory approval in September 2024, reached its first clinical site at Synaptic Health in June 2025, and was described as available for sale in Canada by August 2026. Awards in 2024 and 2025 added external recognition, while participation in the Mobility Unlimited Hub cohort was announced in 2025. These signals point to a transition from engineering and funding toward market adoption.